Malignant tumor
Conditions
Interventions
18F-GPC3P and 18F-FDG PET imaging group:Injection of 18F-GPC3P molecular probe
68Ga-GPC3P and 18F-FDG PET imaging group:Injection of 68Ga-GPC3P molecular probe
Sponsors
The First Affiliated Hospital of Guilin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged 18 or above, male or female; 2.The study participants possess behavioral capacity, understand and have voluntarily signed the informed consent form; 3.Patients initially diagnosed with malignant tumors or those who have previously been diagnosed with malignant tumors and have undergone treatment;
Exclusion criteria
Exclusion criteria: 1. Patients in critical condition requiring emergency care 2. Drug and/or alcohol abusers, individuals with allergic constitution 3. Women who are planning pregnancy, pregnant, or breastfeeding 4. Individuals with bacterial, viral, or fungal infections requiring systemic treatment 5. Subjects deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor lesion identification index;Tumor lesion identification with radiotracer;Adverse reactions of radiotracer; | — |
Countries
China
Contacts
Public ContactFu Wei
The First Affiliated Hospital of Guilin Medical University
Outcome results
None listed